How mutant CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 4 II SUPPL., 1996, Pages

  Pier, Gerald B ^a,b   Grout, Martha ^a   Zaidi, Tanweer S ^a   Goldberg, Joanna B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL MODEL; BACTERIUM ADHERENCE; CONFERENCE PAPER; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; INTERNALIZATION; LUNG INFECTION; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM;

EID: 0029961331     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm/154.4_pt_2.s175     Document Type: Conference Paper

References (35)

1. Pier, G. B., M. Grout, T. S. Zaidi, J. C. Olsen, L. G. Johnson, J. R. Yankaskas, and J. B. Goldberg. 1996. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science 271:64-67.
2. Welsh, M. J., M. P. Anderson, D. P. Rich, H. A. Berger, and D. N. Sheppard. 1994. The CFTR chloride channel. In W. B. Guggino, editor. Chloride Channels: Current Topics in Membranes. Vol. 42. Academic Press, Inc., San Diego. 153-171.
3. Saiman, L., and A. Prince. 1993. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J. Clin. Invest. 92:1875-1880.
4. Zar, H., L. Saiman, L. Quittell, and A. Prince. 1995. Binding of Pseudomonas aeruginosa to respiratory epithelial cells from patients with various mutations in the cystic fibrosis transmembrane regulator. J. Pediatr. 126:230-233.
5. Imundo, L., J. Barasch, A. Prince, and Q. Al-Awqati. 1995. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc. Natl. Acad. Sci. U.S.A. 923:3019-3023.
6. Plotkowski, M. C., M. Chevillard, D. Pierrot, D. Altemayer, and E. Puchelle. 1992. Epithelial cells from cystic fibrosis patients do not possess specific Pseudomonas aeruginosa-adhesive properties. J. Med. Microbiol. 36:104-111.
7. Cervin, M. A., D. A. Simpson, A. L. Smith, and S. Lory. 1994. Differences in eukaryotic cell binding of Pseudomonas. Microb. Pathog. 17:291-299.
8. Falkow, S., R. R. Isberg, and D. A. Portnoy. 1992. The interaction of bacteria with mammalian cells. Annu. Rev. Cell Biol. 8:333-363.
9. Orikasa, S., and F. Hinman, Jr. 1977. Reaction of the vesical wall to bacterial penetration: resistance to attachment, desquamation and leukocyte activity. Invest. Urol. 15:185-193.
10. Dalal, E., O. Medalia, O. Harari, and M. Aronson. 1994. Moderate stress protects female mice against bacterial infection of the bladder by eliciting uroepithelial shedding. Infect. Immun. 62:5505-5510.
11. Fleiszig, S. M. J., T. S. Zaidi, and G. B. Pier. 1995. Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro. Infect. Immun. 63:4072-4077.
12. St. Gerne, III, J. W., and S. Falkow. 1991. Loss of capsule expression by Hemophilus influenzae type b results in enhanced adherence to and invasion of human cells. Infect. Immun. 59:1325-1333.
13. Rubens, C. E., S. Smith, M. Hulse, E. Y. Chi, and G. van Belle. 1992. Respiratory epithelial cell invasion by group B streptococci. Infect. Immun. 60:5157-5163.
14. Olsen, J. C., L. G. Johnson, M. J. Stutts, B. Sarkadi, J. R. Yankaskas, R. Swanstrom, and R. C. Boucher. 1992. Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer. Hum. Gene Ther. 3:253-266.
15. Sarkadi, B., D. Bauzon, W. R. Huckle, H. S. Earp, A. Berry, H. Suchindran, E. M. Price, J. C. Olsen, R. C. Boucher, and G. A. Scarborough. 1992. Biochemical characterization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis epithelial cells. J. Biol. Chem. 267:2087-2095.
16. Nunn, D., S. Bergman, and S. Lory. 1990. Products of 3 accessory genes, pilB, pilC, and pilD, are required for biogenesis of Pseudomonas aeruginosa pili, J. Bacteriol. 172:2911-2919.
17. Totten, P. A., J. C. Lara, and S. Lory. 1990. The rpoN gene product of Pseudomonas aeruginosa is required for expression of diverse genes, including the flagetlin gene. J. Bacteriol. 172:389-396.
18. Rosner, B. 1990. Analysis of variance. Fundamentals of Biostatistics. Duxbury Press, Boston. 498-503.
19. Hatano, K., J. B. Goldberg, and G. B. Pier. 1993. Pseudomonas aeruginosa lipopolysaccharide: evidence that the O-side chains and common antigens are on the same molecule. J. Bacterial. 175:5117-5128.
20. Tang, H., M. Kays, and A. Prince. 1995. Role of Pseudomonas aeruginosa pili in acute pulmonary infection. Infect. Immun. 63:1278-1285.
21. Denning, G. M., M. P. Anderson, J. F. Amara, J. Marshall, A. E. Smith, and M. J. Welsh. 1992. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358:761-764.
22. Hancock, R. E. W., L. M. Mutharia, L. Chan, R. P. Darveau, D. P. Speert, and G. B. Pier. 1983. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect. Immun. 42:170-177.
23. Mahenthiralingam, E., M. E. Campbell, and D. P. Speert. 1994. Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect. Immun. 62:596-605.
24. Totten, P. A., and S. Lory. 1990. Characterization of the type a flagellin gene from Pseudomonas aeruginosa PAK. J. Bacteriol. 172: 7188-7199.
25. Darveau, R. P., and R. E. W. Hancock. 1983. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J. Bacteriol. 155:831-838.
26. Drewry, D. T., K. C. Symes, G. W. Gray, and S. G. Wilkinson. 1975. Studies of polysaccharide fractions from the lipopolysaccharide of Pseudomonas aeruginosa N.C.T.C. 1999. Biochem. J. 149:93-106.
27. Rowe, P. S., and P. M. Meadow. 1983. Structure of the core oligosaccharide from the lipopolysaccharide of Pseudomonas aeruginosa PAC1R and its defective mutants. Eur. J. Biochem. 132:329-337.
28. Jarrell, K. and A. M. Kropinski. 1977. The chemical composition of the lipopolysaccharide from Pseudomonas aeruginosa strain PAO and a spontaneously derived rough mutant. Microbios 19:103-116.
29. Coyne, M. J., K. S. Russell, C. L. Coyle, and J. B. Goldberg. 1994. The Pseudomonas aeruginosa algC gene encodes phosphoglucomutase, required for the synthesis of a complete lipopolysaccharide core. J. Bacteriol. 176:3500-3507.
30. Evans, D. J., G. B. Pier, M. J. Coyne, and J. B. Goldberg. 1994. The rfb locus from Pseudomonas aeruginosa strain PA103 promotes the expression of O antigen by both LPS-rough and LPS-smooth isolates from cystic fibrosis patients. Mol. Microbiol. 12:427-434.
31. Goldberg, J. B., K. Hatano, G. S. Meluleni, and G. B. Pier. 1992. Cloning and surface expression of Pseudomonas aeruginosa O antigen in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 89:10716-10720.
32. Schwan, E. T., B. D. Robertson, H. Brade, and J. P. M. van Putten. 1995. Gonococcal rfoF mutants express rd(2) chemotype LPS and do not enter epithelial host cells. Mol. Microbiol. 15:267-275.
33. Roychoudhury, S., N. A. Zielinski, J. D. Devault, J. Kato, D. L. Shinabarger, T. B. May, R. Maharaj, K Kimbara, T. K. Misra, and A. M. Chakrabarty. 1991. Pseudomonasaeruginosa infection in cystic fibrosis: biosynthesis of alginate as a virulence factor. In J. Y. Homma, H. Tanimoto, I. A., Holder, N. Hoiby, and G. Doring, editors. Pseudomonas aeruginosa in Human Diseases: Antibiotics and Chemotherapy. Vol. 44. S. Karger AG, Basel. 63-67.
34. Vishwanath, S., R. Ramphal., C. M. Guay, D. DesJardins, and G. B. Pier. 1988. Respiratory mucin inhabits the opsonophagocytic killing of Pseudomonas aeruginosa. Infect. Immun. 56:2218-2222.
35. Høiby, N., and C. Koch. 1990. Cystic fibrosis. I. Pseudomonas aeruginosa infection in cystic fibrosis and its management. Thorax 45: 881-884.